News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Wheeler Cameron
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 15,000 options to buy
@ $44.68, valued at
$670.2k
|
|
| 06/21/2022 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 20,000 options to buy
@ $9.36, valued at
$187.2k
|
|
| 07/30/2021 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Granted 43,000 options to buy
@ $17, valued at
$731k
|
|
| 07/28/2021 |
3
| Wheeler Cameron (Director) has filed a Form 3 on Nuvalent, Inc. |
| 10/01/2020 |
3
| Wheeler Cameron (Director) has filed a Form 3 on Oncorus, Inc. |
| 06/11/2019 |
4/A
| Wheeler Cameron (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 15,580 options to buy
@ $19.51, valued at
$304k
|
|
| 06/10/2019 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 15,580 options to buy
@ $19.51, valued at
$304k
|
|
| 03/29/2018 |
4
| Wheeler Cameron (Director) has filed a Form 4 on Homology Medicines, Inc.|
Txns:
| Granted 31,160 options to buy
@ $16, valued at
$498.6k
|
|
| 03/27/2018 |
3
| Wheeler Cameron (Director) has filed a Form 3 on Homology Medicines, Inc. |
|
|